Novo, which in September said it secured Indian regulatory approval to import and sell Ozempic, on Thursday said it hoped to ...

Novo Nordisk may continue testing an Ozempic pill for Alzheimer's after early trials showed limited biological effects ...

Novo Nordisk A/S left open the door for additional work on its pill version of Ozempic for Alzheimer’s disease after a pair of failed trials, saying that patients showed a biological response in a ...

Novo Nordisk (NYSE:NVO) is pressing ahead with its Alzheimer's ambitions even after two pill trials for Ozempic came up empty ...

Pennsylvania has quietly moved to limit access next year to popular weight-loss drugs like Ozempic and Wegovy for residents ...

AFTER years of trying to slim down, a mother has opened up on losing over four stone without fat jabs. There was no Mounjaro ...

Stocks in Asia and Europe set the pace on Thursday, while US futures held gains as traders bet that a Federal Reserve ...

By Deena Beasley and Julie Steenhuysen SAN DIEGO, Dec 3 (Reuters) - Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people with early ...

Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

A rally that put the stock market within a striking distance of its all-time highs struggled to gain a whole lot of traction ...

US stock futures held gains as Asian and European equities set the pace on Thursday, with traders betting that a Federal Reserve interest rate cut will drive a global rally into year-end.